Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

Sanofi

Protein Subunit Vaccines Come In From The Cold To Offer India A Ray Of Hope
Protein Subunit Vaccines Come In From The Cold To Offer India A Ray Of HopeY SasankJul 6, 2021 09:47 AM +05:30 IST
From Novavax To Sanofi, Pharmaceutical Companies Develop A New Type Of Covid-19 Vaccine  
From Novavax To Sanofi, Pharmaceutical Companies Develop A New Type Of Covid-19 Vaccine  Bhaswati Guha Majumder Jun 7, 2021 08:02 PM +05:30 IST
GSK Back In Covid-19 Vaccination Race, Vaccine Candidate Jointly Developed By GSK-Sanofi Reports Success In Phase 2 Trial
GSK Back In Covid-19 Vaccination Race, Vaccine Candidate Jointly Developed By GSK-Sanofi Reports Success In Phase 2 TrialSwarajya StaffMay 17, 2021 12:49 PM +05:30 IST
Why India Should Not Bring A Vaccine Developed By Private Sector Under ‘Compulsory Licence’; History Suggests It Might
Why India Should Not Bring A Vaccine Developed By Private Sector Under ‘Compulsory Licence’; History Suggests It MightSatish ViswanathanSep 15, 2020 01:04 PM +05:30 IST
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEO
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEOIANSMay 30, 2020 01:06 PM +05:30 IST
Explained: What Is Herd Immunity And Can It Help Slow The Spread Of Coronavirus?
Explained: What Is Herd Immunity And Can It Help Slow The Spread Of Coronavirus?Swarajya StaffApr 2, 2020 11:19 AM +05:30 IST
Sanofi’s Dengue Vaccine Gets FDA Nod But Conditions Apply; Dengvaxia Is World’s First Vaccine Against Dengue
Sanofi’s Dengue Vaccine Gets FDA Nod But Conditions Apply; Dengvaxia Is World’s First Vaccine Against DengueSwarajya StaffMay 2, 2019 08:06 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype